mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.

Utkarsh Kohli
Lavina Desai
Devyani Chowdhury
Ashraf S Harahsheh
Alexandra B Yonts
Annette Ansong
Arash Sabati
Hoang H Nguyen
Tarique Hussain
Bishara J. Freij, Beaumont Health


In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.